RecruitingNCT01281735
International Chronic Myeloid Leukemia Pediatric Study
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
Sponsor
Poitiers University Hospital
Enrollment
750 participants
Start Date
Jan 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Eligibility
Max Age: 18 Years
Inclusion Criteria2
- patients less than 18 years of age
- diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases
Exclusion Criteria1
- patients more than 18 years of age at diagnosis of CML
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01281735
Related Trials
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
NCT0699467611 locations
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
NCT062298601 location
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
NCT062367241 location
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069740 locations
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
NCT068177201 location